Medical Therapy in Peripheral Artery Disease and Critical Limb Ischemia
- PMID: 27181397
- DOI: 10.1007/s11936-016-0464-8
Medical Therapy in Peripheral Artery Disease and Critical Limb Ischemia
Abstract
Peripheral artery disease (PAD) comprises atherosclerosis of the aorta and lower extremities. Many patients with PAD are asymptomatic, while others present with intermittent claudication (IC) or critical limb ischemia (CLI). Defined as rest pain or tissue loss that persists for >2 weeks, CLI represents the most severe clinical manifestation of PAD and is associated with an increased risk of limb loss and death. Patients with PAD, including those with CLI, are underdiagnosed and undertreated. In addition to smoking cessation, medical therapy with an antiplatelet agent and statin is recommended for all patients with PAD. Regular exercise has been shown to improve walking distance and quality of life in patients with symptomatic PAD and should be incorporated into each patient's treatment plan. In patients who have CLI and in those with persistent lifestyle-limiting claudication despite optimal medical therapy and an exercise program, revascularization is indicated for limb salvage and symptom relief, respectively. Consensus guidelines currently support an endovascular first approach to revascularization in the majority of cases. Surgical procedures provide an alternative to endovascular therapy in select cases.
Keywords: Critical limb ischemia; Peripheral artery disease; Therapy; Vascular disease.
Similar articles
-
Peripheral Arterial Disease – Diagnosis and Treatment: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Nov. SBU Yellow Report No. 187. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Nov. SBU Yellow Report No. 187. PMID: 28876730 Free Books & Documents. Review.
-
Treatment Strategies for Patients With Peripheral Artery Disease [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May. Report No.: 13-EHC090-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May. Report No.: 13-EHC090-EF. PMID: 23844447 Free Books & Documents. Review.
-
Peripheral artery disease: therapeutic advances.Expert Rev Cardiovasc Ther. 2008 Apr;6(4):539-53. doi: 10.1586/14779072.6.4.539. Expert Rev Cardiovasc Ther. 2008. PMID: 18402543 Review.
-
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.J Vasc Surg. 2016 Oct;64(4):1009-1017.e3. doi: 10.1016/j.jvs.2016.03.429. Epub 2016 May 18. J Vasc Surg. 2016. PMID: 27209402
-
Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial.J Vasc Surg. 2006 Jun;43(6):1175-82. doi: 10.1016/j.jvs.2005.12.069. J Vasc Surg. 2006. PMID: 16765234 Clinical Trial.
Cited by
-
Keratose Hydrogel Drives Differentiation of Cardiac Vascular Smooth Muscle Progenitor Cells: Implications in Ischemic Treatment.Stem Cell Rev Rep. 2023 Oct;19(7):2341-2360. doi: 10.1007/s12015-023-10574-6. Epub 2023 Jul 1. Stem Cell Rev Rep. 2023. PMID: 37392292
-
Deep Venous Arterialization: Background, Patient Selection, Technique, Outcomes and Follow-up, and Future Implementation.Semin Intervent Radiol. 2023 Jun 16;40(2):183-192. doi: 10.1055/s-0043-57264. eCollection 2023 Apr. Semin Intervent Radiol. 2023. PMID: 37333738 Free PMC article. Review.
-
Endovascular Revascularization and Outcomes of Critical Limb-Threatening Ischemia in Trinidad and Tobago: The EVENT Pilot Study-Challenges in a Limited-Resource, Caribbean Setting.Cardiol Ther. 2023 Sep;12(3):511-524. doi: 10.1007/s40119-023-00322-9. Epub 2023 Jun 17. Cardiol Ther. 2023. PMID: 37329412 Free PMC article.
-
Influence of Nursing Intervention Based on Risk Assessment Model on Self-Efficacy and Postoperative Rehabilitation of Surgical Patients.J Healthc Eng. 2022 Apr 13;2022:6750320. doi: 10.1155/2022/6750320. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Jun 28;2023:9836029. doi: 10.1155/2023/9836029. PMID: 35463686 Free PMC article. Retracted.
-
Hypoxia pretreatment improves the therapeutic potential of bone marrow mesenchymal stem cells in hindlimb ischemia via upregulation of NRG-1.Cell Tissue Res. 2022 Apr;388(1):105-116. doi: 10.1007/s00441-021-03562-0. Epub 2022 Jan 29. Cell Tissue Res. 2022. PMID: 35091805
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
